Centre Hospitalier Universitaire de La Réunion
Saint-Pierre, 97448, France
NCT Number: NCT02899546
Septi-PICC study aims at assessing incidence of Peripherally Inserted Central Catheter (PICC)-related infections among patients managed in the University Hospital of La Reunion for PICC setting.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Saint-Pierre, 97448, France
Septi-PICC is a prospective single-center study of infections related to PICCs setting at the South tertiary site of the University Hospital of La Reunion over one year with a follow-up of 6 months per patient.
All the complications such as thromboembolic, are collected during the follow-up.
It is planned a convenience sample of 400 patients over 18 years of age, except pregnant women.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year with 6 months follow-up
Time frame: 6 months follow-up
Time frame: 6 months follow-up
Centre Hospitalier Universitaire de la Réunion
Other
Suivi Prospectif Des Complications Infectieuses liées Aux PICC Lines en Milieu Tropical
Acronym: Septi-PICC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06851585
Catheterization, Catheterization, Peripheral
Poitiers, France
View Trial DetailsNCT00516906
Catheterization
View Trial DetailsNCT04865783
Anesthetics, Intravenous, Catheterization
Aabenraa, Denmark
View Trial DetailsNCT06271499
Cannulation, Catheterization
Ankara, Turkey (Türkiye)
View Trial Details